Find and Pitch Jounalists, Get Your Story Covered

Tags: biotechnology drug development Drug prices research vaccines

	Profile	Recent Articles on Subject
1	Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States insurancedigital health	Judge dismisses lawsuit against Wells Fargo over prescription drug costs - 23 days ago New bipartisan legislation would force insurers, PBMs to sell pharmacy businesses - 4 months ago Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs - 5 months ago PBMs battle bipartisan scrutiny as lawmakers eye industry reform - 9 months ago Federal Trade Commission to sue three largest PBMs: WSJ - 9 months ago Optum Rx reaches $20M settlement with Justice Department over opioid prescribing - 10 months ago Amazon expands drug subscription program to Medicare members - 10 months ago CMS asks health plans, PBMs to ease up on independent pharmacies - over 1 year ago CVS overhauls how its retail pharmacies charge for prescription drugs - over 1 year ago Optum Rx moves 8 insulins to preferred formulary status as pressure mounts on PBMs - over 1 year ago Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs - 5 months ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Amazon's RxPass Shown to Improve Days' Supply, Refills, and Out-of-Pocket Costs for Common Medications - 2 months ago
3	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Ozempic/Wegovy and 14 Other Drugs Selected for Medicare Price Negotiation - 3 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and more - 3 months ago STAT+: Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program - 4 months ago STAT+: Pharmalittle: We’re reading about Medicare obesity drug coverage, a first-of-its-kind 340B analysis, and more - 5 months ago STAT+: Pharmacies sue GoodRx and PBMs over ‘illegal’ reimbursement fees - 5 months ago STAT+: Pharmalittle: We’re reading about Medicaid coverage of obesity drugs, a death in a sickle cell trial, and more - 5 months ago STAT+: Sales from controversial drug discount program rose to $63 billion last year - 6 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 7 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 9 months ago STAT+: Pharmalittle: We’re reading about Ozempic and an eye condition, a failed Roche cancer drug trial, and more - 10 months ago STAT+: Virginia governor vetoes plans to create a prescription drug affordability board - about 1 year ago STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - about 1 year ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - about 1 year ago STAT+: White House to hold a listening session on reforming pharmacy benefit managers - about 1 year ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - about 1 year ago STAT+: Oregon suspends a portion of its drug transparency law found to be unconstitutional - about 1 year ago STAT+: Pharmalittle: We’re reading about a lawsuit against J&J, Express Scripts dealings, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - over 1 year ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - over 1 year ago STAT+: Pharmalittle: CVS to overhaul how it’s paid for drugs; Biden drug-shortage plan won’t expand chemo supplies - over 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - over 1 year ago STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds - over 1 year ago STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs - over 1 year ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	What to expect in the sequel to Medicare’s drug price negotiation program - 3 months ago The drugs hit hardest by Medicare price negotiations - 8 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - about 1 year ago
6	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy - 3 months ago STAT+: Higher insurance costs eat into savings from drug pricing law by more than expected - 7 months ago STAT+: House hearing keeps pressure on PBM practices while Congress considers reforms - 9 months ago STAT+: Senate panel considers Medicare policy fixes to drug shortages - over 1 year ago STAT+: Biden defends Trump-era drug pricing rule on copay accumulators - over 1 year ago
7	Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois HealthcareNews	Few state Medicaid programs cover GLP-1s for obesity: KFF - 5 months ago Texas sues major PBMs, pharma companies over high insulin prices - 7 months ago
8	Katie Adams MedCity News Editor. Exeter, New Hampshire editingjournalism	An Upcoming White House Decision May Jeopardize Americans’ Access to Life-Saving Drugs - 8 months ago
9	Susanna Vogel Healthcare Dive Currently at Healthcare Dive. Seen in various outlets. Greenpoint healthcarejournalism	PBMs battle bipartisan scrutiny as lawmakers eye industry reform - 9 months ago
10	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Contradictory coverage decisions in North Carolina - 9 months ago STAT+: Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles - about 1 year ago

Journalists covering prescription drug coverage